Mesh Macrocarriers for Scalable Microglia Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protocols for producing microglial and macrophage-like cells face challenges in scalability, requiring significant resources and additional maturation steps, and existing carriers do not support the adherence and outgrowth of embryoid bodies effectively in bioreactors.
Innovation Solution
A novel protocol using a mesh membrane as a macrocarrier for iPSC-derived macrophage- and microglia-like/precursor cell production, providing structural support for embryoid bodies, facilitating adherence, outgrowth, and easy harvesting, while allowing for better nutrient and gas diffusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional protocols are used for producing microglial and macrophage-like cells, then cell production is achieved, but scalability is limited and resource requirements are high
Solution Approach 1:
The patent transitions from traditional 2D monolayer culture to 3D embryoid body culture on mesh macrocarriers. This dimensional change enables better nutrient diffusion, improved cell differentiation, and scalable production in bioreactor systems, directly addressing the productivity and resource utilization contradictions
Solution Approach 2:
The patent employs porous mesh macrocarriers with specific pore sizes (5-180 μm) that facilitate nutrient and gas diffusion while providing structural support for embryoid bodies. This porous structure enables scalable cell production without proportionally increasing resource consumption, resolving the contradiction between productivity and resource requirements
2Reliability
If additional maturation steps are implemented to improve cell quality, then cell phenotype accuracy is improved, but production time and process complexity increase
Solution Approach 1:
The patent incorporates neural environment components and maturation factors during the embryoid body differentiation phase itself, rather than requiring separate post-differentiation maturation steps. This preliminary action achieves both high phenotype accuracy and simplified processing, resolving the contradiction between reliability and device complexity
3Ease of operation
If embryoid bodies are cultured without proper structural support, then culture simplicity is maintained, but adherence and outgrowth are insufficient
Solution Approach 1:
The patent introduces mesh macrocarriers as an intermediary substrate that provides structural support for embryoid body adherence and outgrowth. These carriers serve as a bridge between simple suspension culture and complex structured culture systems, maintaining ease of operation while achieving high manufacturing precision through controlled 3D cell development
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables scalable production of microglia-like and macrophage-like cells with improved purity and cryopreservation capabilities, reducing material and personnel costs and simplifying the harvesting process.
Implementation Method 1
allowing for better nutrient and gas diffusion
Data Source
AI summary
The present invention relates to methods allowing adherence and outgrowth of embryoid bodies (EBs) using macrocarriers. The methods of the invention are useful for an up-scaled production of myeloid cells, such as macrophage- and microglia-like/-precursor cells, in a bioreactor system. The invention further relates to microglia-like cells or microglial precursor cells obtainable by these methods that are cryopreservable. The invention also concerns a porous macrocarrier coated with a material facilitating cell adherence.